AtriCure, a provider of Atrial Fibrillation (Afib) medical device, and Endoscopic Technologies, d/b/a Estech, have entered into a definitive merger agreement under which AtriCure has agreed to acquire Estech. Under the agreement, AtriCure ...
Ocera Therapeutics has entered into a technology transfer and license deal with the Roche Group, including the Research and Early Development arms of both Genentech and Roche, for rights to its Macrocyclic Template Chemistry (MATCH) ...
Tags: Ocera Therapeutics, License Deal
Ocera Therapeutics (Nasdaq:OCRX) today announced that it has entered into a Technology Transfer and License Agreement with the Roche Group, including the Research and Early Development arms of both Genentech and Roche, for rights to its ...
Tags: Ocera Therapeutics, Roche, Macrocyclic Template Chemistry
Stelis Biopharma and Pieris, a next generation therapeutic protein R&D firm, have started a long-term collaboration for clinical development and commercialization of multiple novel Anticalin-based protein therapeutics worldwide, primarily ...
Genzyme, a Sanofi company, has obtained an approval from Health Canada for its Lemtrada (alemtuzumab) for the treatment of relapsing remitting multiple sclerosis (RRMS). Health Canada has approved Lemtrada for the management of adult ...
US-based Agios Pharmaceuticals has announced an extension of one additional year to the period of exclusivity for their strategic cancer metabolism collaboration with Celgene. Celgene research president Dr Thomas Daniel noted the quality ...
Covagen has announced that the company has secured CHF42m in a tranched Series B financing with an option to obtain an additional CHF14m that would increase the total amount of the financing round to CHF56m. This financing will mainly ...
Proteostasis Therapeutics and Biogen Idec have collaborated to research and develop new therapies based on the inhibition of Usp14, a deubiquitinating enzyme, for the treatment of certain neurodegenerative disorders. Under the deal, ...
Druggability Technologies (DRGT) has entered into a multi-year collaboration deal with Bayer HealthCare that will deploy DRGT's proprietary Super-API platform to support Bayer HealthCare's formulation efforts directed at enhancing compound ...
Tags: Drugs Discovery, Bayer Healthcare
NanoViricides has received results of detailed lab analysis studies from the initial non-GLP toxicology studies of intravenously administered FluCide. No overt adverse safety and toxicology effects were observed in this study of the ...
Taiwan-based JHL Biotech and Switzerland-based Selexis have formed a biologic drug development alliance to serve the biopharmaceutical industry. JHL Biotech and Selexis have signed a non-exclusive strategic agreement to provide seamless ...
Tags: Health, Medicine, taiwan, Biologic Drug
BioDelivery Sciences International (BSDI) announced that it engaged in a positive meeting with the US Food and Drug Administration (FDA) regarding the clinical development program for Clonidine topical gel that will allow the program to ...
CDRD Ventures, the commercialization vehicle of The Centre for Drug Research and Development (CDRD), has announced the launch of a new spin-off company, Sitka Biopharma is a biotechnology company developing a new bladder cancer treatment. ...
The US Food and Drug Administration (FDA) has granted orphan drug designation to Conatus Pharmaceuticals' drug candidate emricasan for the treatment of liver transplant patients with reestablished fibrosis to delay the progression to ...
Theraclone Sciences has received notification from the Biomedical Advanced Research and Development Authority (BARDA) informing the company that their proposal, 'Broad-spectrum anti-influenza A M2e fully human monoclonal antibody TCN-032: ...